Osimertinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4134 publications
Optimal Use of Targeted Therapy and Immunotherapy in Early-Stage, Resectable Non-Small Cell Lung Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 23, 2026
Normal Ovarian Reserve During Long-Term Osimertinib Therapy in a Patient With Li-Fraumeni Syndrome: A Case Report and Literature Review.
Journal: Cureus
Published: June 18, 2026
Clinicogenomic analysis of EGFR-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.
Journal: Science translational medicine
Published: June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026
A Case of EGFR-mutant Lung Adenocarcinoma with Secondary SCLC Transformation and ALK Fusion after Osimertinib Treatment
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 15, 2026
Cochlear implantation in a patient with profound bilateral deafness receiving osimertinib for advanced lung adenocarcinoma: a case report
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: June 10, 2026
Perioperative Molecular Testing in Non-small Cell Lung Cancer
Journal: Zentralblatt fur Chirurgie
Published: June 08, 2026
Response to the Letter to the Editor Re: "Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC".
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2026
Uncovering functional variants using a high-efficiency PE3-based screening platform.
Journal: Science advances
Published: June 05, 2026
State-of-the-Art Advances and Management of Unresectable Locally Advanced (stage III) Non-Small Cell Lung Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 03, 2026
Autoimmune pulmonary alveolar proteinosis induced by brigatinib: a case report and literature review
Autoimmune pulmonary alveolar proteinosis induced by brigatinib: a case report and literature review
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026
Last Updated: 06/30/2026